BioSpace News Archive

Deals

Natera Announces Pricing of Follow-On Offering

Natera, Inc today announced the pricing of its underwritten public offering of 4,500,000 shares of its common stock at a price to the public of $113.00 per share. Closing of the offering is expected to occur on July 26, 2021.

July 22, 2021
·
4 min read
Veterinary Holters Market: Rise in demand for cardiac monitoring devices in veterinary care to drive the market

Holter monitor is used in non-invasive techniques to monitor cardiac rhythm over a long period of time.

July 22, 2021
·
5 min read
Thoracic Surgery Market: Growing preference of patients toward minimal invasive thoracic surgeries is expected to drive the market

A thoracic surgery involves any procedure or operation related to chest organs including heart, lungs, esophagus, and trachea.

July 22, 2021
·
5 min read
North America Spatial OMICS Market is Estimated to Contribute the Dominant Growth Share to 2030 | TMR Research Study

The growing demand from biomarkers and the rising applications of transcriptomics technologies across the globe will prove to be a boon for the growth of the spatial OMICS market during the assessment period of 2020-2030.

July 22, 2021
·
3 min read
Sharps Containers Market Detailed Analysis and Forecast by 2028

The demand within the global sharps containers market is slated escalate in the years to follow.

July 22, 2021
·
3 min read
Patient Recliner Market: The launch of novel products by leading vendors is expected to augur growth of the market

In hospitals, the test region, treatment centres, and medical departments, the most prevalent mechanisms are recliners.

July 22, 2021
·
4 min read
Medical Drones Market: Rise in demand for Quick Delivery of Medicines to Fuel the market

Medical Drones industry can be followed back to late 1800 and mid 1900 for military activities.

July 22, 2021
·
4 min read
Cellular Health Screening Market Review Report with Accurate Forecast by 2030

Cellular health screening is a progressive innovation that is utilized for fast analysis of health at a cellular level.

July 22, 2021
·
4 min read
Business

Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein Degrader ARV-471

Arvinas, Inc. and Pfizer Inc. today announced a global collaboration to develop and commercialize ARV-471, an investigational oral PROTAC® (PROteolysis TArgeting Chimera) estrogen receptor protein degrader.

July 22, 2021
·
17 min read
Business

Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter 2021 Financial Results and Operational Highlights

Oncolytics Biotech® Inc. announced that it will host a conference call and webcast on Friday, August 6, 2021, at 8:00 a.m. ET to discuss a corporate update and financial results for the second quarter 2021.

July 22, 2021
·
4 min read